Cargando…

Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis

In the present study, we aimed to estimate the concentrations of cytokines (interleukin 6, IL-6, tumor necrosis factor-α, TNF-α) and auto-antibodies (rheumatoid factor IgM isotype, IgM-RF, antinuclear auto-antibodies, ANA, anti–cyclic citrullinated peptide antibodies IgG isotype, IgG anti-CCP3.1, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Siloşi, Isabela, Boldeanu, Lidia, Biciuşcă, Viorel, Bogdan, Maria, Avramescu, Carmen, Taisescu, Citto, Padureanu, Vlad, Boldeanu, Mihail Virgil, Dricu, Anica, Siloşi, Cristian Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486125/
https://www.ncbi.nlm.nih.gov/pubmed/28629188
http://dx.doi.org/10.3390/ijms18061304
_version_ 1783246207646171136
author Siloşi, Isabela
Boldeanu, Lidia
Biciuşcă, Viorel
Bogdan, Maria
Avramescu, Carmen
Taisescu, Citto
Padureanu, Vlad
Boldeanu, Mihail Virgil
Dricu, Anica
Siloşi, Cristian Adrian
author_facet Siloşi, Isabela
Boldeanu, Lidia
Biciuşcă, Viorel
Bogdan, Maria
Avramescu, Carmen
Taisescu, Citto
Padureanu, Vlad
Boldeanu, Mihail Virgil
Dricu, Anica
Siloşi, Cristian Adrian
author_sort Siloşi, Isabela
collection PubMed
description In the present study, we aimed to estimate the concentrations of cytokines (interleukin 6, IL-6, tumor necrosis factor-α, TNF-α) and auto-antibodies (rheumatoid factor IgM isotype, IgM-RF, antinuclear auto-antibodies, ANA, anti–cyclic citrullinated peptide antibodies IgG isotype, IgG anti-CCP3.1, anti-cardiolipin IgG isotype, IgG anti-aCL) in serum of patients with eRA (early rheumatoid arthritis) and HCVrA (hepatitis C virus-related arthropathy) and to assess the utility of IL-6, TNF-α together with IgG anti-CCP and IgM-RF in distinguishing between patients with true eRA and HCVrA, in the idea of using them as differential immunomarkers. Serum samples were collected from 54 patients (30 diagnosed with eRA-subgroup 1 and 24 with HCVrA-subgroup 2) and from 28 healthy control persons. For the evaluation of serum concentrations of studied cytokines and auto-antibodies, we used immunoenzimatique techniques. The serum concentrations of both proinflammatory cytokines were statistically significantly higher in patients of subgroup 1 and subgroup 2, compared to the control group (p < 0.0001). Our study showed statistically significant differences of the mean concentrations only for ANA and IgG anti-CCP between subgroup 1 and subgroup 2. We also observed that IL-6 and TNF-α better correlated with auto-antibodies in subgroup 1 than in subgroup 2. In both subgroups of patients, ROC curves indicated that IL-6 and TNF-α have a higher diagnostic utility as markers of disease. In conclusion, we can say that, due to high sensitivity for diagnostic accuracy, determination of serum concentrations of IL-6 and TNF-α, possibly in combination with auto-antibodies, could be useful in the diagnosis and distinguishing between patients with true eRA and HCV patients with articular manifestation and may prove useful in the monitoring of the disease course.
format Online
Article
Text
id pubmed-5486125
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-54861252017-06-29 Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis Siloşi, Isabela Boldeanu, Lidia Biciuşcă, Viorel Bogdan, Maria Avramescu, Carmen Taisescu, Citto Padureanu, Vlad Boldeanu, Mihail Virgil Dricu, Anica Siloşi, Cristian Adrian Int J Mol Sci Article In the present study, we aimed to estimate the concentrations of cytokines (interleukin 6, IL-6, tumor necrosis factor-α, TNF-α) and auto-antibodies (rheumatoid factor IgM isotype, IgM-RF, antinuclear auto-antibodies, ANA, anti–cyclic citrullinated peptide antibodies IgG isotype, IgG anti-CCP3.1, anti-cardiolipin IgG isotype, IgG anti-aCL) in serum of patients with eRA (early rheumatoid arthritis) and HCVrA (hepatitis C virus-related arthropathy) and to assess the utility of IL-6, TNF-α together with IgG anti-CCP and IgM-RF in distinguishing between patients with true eRA and HCVrA, in the idea of using them as differential immunomarkers. Serum samples were collected from 54 patients (30 diagnosed with eRA-subgroup 1 and 24 with HCVrA-subgroup 2) and from 28 healthy control persons. For the evaluation of serum concentrations of studied cytokines and auto-antibodies, we used immunoenzimatique techniques. The serum concentrations of both proinflammatory cytokines were statistically significantly higher in patients of subgroup 1 and subgroup 2, compared to the control group (p < 0.0001). Our study showed statistically significant differences of the mean concentrations only for ANA and IgG anti-CCP between subgroup 1 and subgroup 2. We also observed that IL-6 and TNF-α better correlated with auto-antibodies in subgroup 1 than in subgroup 2. In both subgroups of patients, ROC curves indicated that IL-6 and TNF-α have a higher diagnostic utility as markers of disease. In conclusion, we can say that, due to high sensitivity for diagnostic accuracy, determination of serum concentrations of IL-6 and TNF-α, possibly in combination with auto-antibodies, could be useful in the diagnosis and distinguishing between patients with true eRA and HCV patients with articular manifestation and may prove useful in the monitoring of the disease course. MDPI 2017-06-19 /pmc/articles/PMC5486125/ /pubmed/28629188 http://dx.doi.org/10.3390/ijms18061304 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Siloşi, Isabela
Boldeanu, Lidia
Biciuşcă, Viorel
Bogdan, Maria
Avramescu, Carmen
Taisescu, Citto
Padureanu, Vlad
Boldeanu, Mihail Virgil
Dricu, Anica
Siloşi, Cristian Adrian
Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis
title Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis
title_full Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis
title_fullStr Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis
title_full_unstemmed Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis
title_short Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis
title_sort serum biomarkers for discrimination between hepatitis c-related arthropathy and early rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486125/
https://www.ncbi.nlm.nih.gov/pubmed/28629188
http://dx.doi.org/10.3390/ijms18061304
work_keys_str_mv AT silosiisabela serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT boldeanulidia serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT biciuscaviorel serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT bogdanmaria serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT avramescucarmen serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT taisescucitto serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT padureanuvlad serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT boldeanumihailvirgil serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT dricuanica serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis
AT silosicristianadrian serumbiomarkersfordiscriminationbetweenhepatitiscrelatedarthropathyandearlyrheumatoidarthritis